Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Evommune Inc. (EVMN) had Normalized Pre-Tax Income of $7.00M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$7.00M |
|
$-66.81M |
|
-- |
|
$7.00M |
|
-- |
|
$7.00M |
|
-- |
|
$7.00M |
|
|
Normalized Pre-Tax Income |
$7.00M |
$7.00M |
|
$-66.81M |
|
$-66.81M |
|
$7.00M |
|
$7.00M |
|
$7.00M |
|
1.51M |
|
1.51M |
|
$-45.29 |
|
$-45.29 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
100.00% |
|
-954.40% |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|